| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.5904 | 57 |
| GSM780708 | Untreated after 4 days (C2_1) | 56.3559 | 61 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.861 | 54 |
| GSM780719 | Untreated after 4 days (C1_2) | 57.3154 | 62 |
| GSM780720 | Untreated after 4 days (C2_2) | 63.0798 | 66 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.0115 | 51 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 58.3193 | 63 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.1012 | 49 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 54.4487 | 59 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 57.1563 | 62 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 57.9654 | 63 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 60.8268 | 65 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 58.3838 | 63 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 61.5611 | 65 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 52.1038 | 54 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 64.0661 | 67 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 53.0837 | 56 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 57.3266 | 62 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 64.3516 | 67 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.3474 | 52 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 64.1833 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 61.0276 | 65 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 56.904 | 62 |